Author

admin

Browsing

President Donald Trump told U.S. troops aboard the USS George Washington at Japan’s Yokosuka Naval Base on Tuesday that the ‘first batch of missiles for Japan’s F-35 fighter jets ‘will arrive this week,’ suggesting that U.S. defense deliveries to Tokyo are moving ahead of schedule.

The comments came during Trump’s hour-long remarks to sailors as part of his wider Asia trip, which included a stop in Malaysia before Japan, where he met with the country’s first female prime minister, Sanae Takaichi, and signed a new U.S.-Japan framework agreement on rare earth minerals. Later this week, Trump is expected to meet with Chinese President Xi Jinping.

Washington has approved several large arms sales to Japan, including advanced AIM-120 AMRAAM and AIM-9X air-to-air missiles designed for F-35s.

Trump praised the U.S.’ alliance with Japan, calling it ‘one of the most remarkable relationships in the entire world.’

Prime Minister Takaichi, sharing the stage with Trump, said Japan was ‘committed to fundamentally reinforcing its defense capability’ and ‘ready to contribute even more proactively to peace and stability in the region.’

Trump also touted Japan’s and the U.S.’ stock markets reaching record highs, saying it was a sign that ‘we’re doing something right.’

Trump’s appearance underscored Washington’s deepening security cooperation with Tokyo as regional tensions with China and North Korea persist. Ahead of his Asia trip this week, Trump has made repeated invitations to meet North Korean leader Kim Jong Un, though no concrete preparations are underway.

This post appeared first on FOX NEWS

House Oversight Committee Chair James Comer, R-Ky., is demanding the Department of Justice (DOJ) conduct a ‘comprehensive’ investigation into former President Joe Biden’s autopen use.

The committee’s GOP majority released a 100-page report on Tuesday morning detailing findings from its months-long probe into Biden’s White House, specifically whether his inner circle covered up signs of mental decline in the ex-president, and if that alleged cover-up extended to executive actions signed via autopen without Biden’s full awareness.

‘Faced with the cognitive decline of President Joe Biden, White House aides — at the direction of the inner circle — hid the truth about the former president’s condition and fitness for office,’ the report said.

The report also detailed a ‘haphazard documentation process’ for pardons made by Biden, which the committee argued left room for doubt over whether the former president made those decisions himself.

‘In the absence of sufficient contemporaneous documentation indicating that cognitively deteriorating President Biden himself made a given executive decision, such decisions do not carry the force of law and should be considered void,’ the GOP report said.

‘The Department of Justice should immediately conduct a review of all executive actions taken by President Biden between January 20, 2021, and January 19, 2025. Given the patterns and findings detailed herein, this review should focus particularly on all acts of clemency. However, it should also include all other types of executive actions.’

In addition to concerns about who signed off on Biden’s executive actions, Comer spent part of the report raising concerns about Hunter Biden’s role in the pardon process.

Fox News Digital previously reported that ex-Biden Chief of Staff Jeff Zients told investigators that Hunter Biden was in the room for some pardon discussions — specifically the controversial preemptive pardons the ex-president gave to his relatives.

‘It was towards the end,’ said a portion of Zients’ transcript included in the report. ‘What comes to mind is the family discussions. But I don’t know — that doesn’t mean that was it. It was the pardons towards the end, very end of the administration. And I think it was a few meetings, not many meetings.’

Comer’s report said, ‘Zients testified that President Biden included his son, Hunter Biden, in the decision-making process for and meetings about pardons.’

‘This apparently included the meeting to discuss the pardons of five Biden family members, Dr. Anthony Fauci, General Mark Milley, and the members of Congress who served on the Select Subcommittee to Investigate the January 6th attack on the United States Capitol, and their staff,’ the report said.

The Oversight Committee called a total of 14 witnesses across three months, mainly consisting of top Biden administration aides — including some who had known him for decades.

Despite nearly 47 hours of interviews and sworn depositions, however, Comer suggested he believed aides covered for Biden even in the committee room.

‘Throughout the Committee’s investigation, senior Biden White House aides presented a perspective of President Biden’s cognitive health completely disconnected from that of the American public,’ the report said.

‘Not one of the Committee’s 14 witnesses was willing to admit that they ever had a concern about President Biden being in cognitive decline. In fact, numerous witnesses could not recall having a single conversation about President Biden’s cognitive health with anyone inside or outside of the White House.’

Comer spent a significant amount of time in the report criticizing former White House physician Dr. Kevin O’Connor. O’Connor’s sworn deposition was among the shortest sit-downs of the investigation, with the doctor having invoked the Fifth Amendment for all questions save for his name.

In a letter obtained by Fox News Digital alongside the report, Comer called for the D.C. Health Board of Medicine to investigate O’Connor — and potentially bar him from practicing medicine.

The GOP report called O’Connor’s alleged decision to not conduct a cognitive exam with Biden during his four-year term ‘reckless’ and accused him of making ‘grossly misleading medical assessments.’

‘His refusal to answer questions about the execution of his duties as physician to the president — combined with testimony indicating that Dr. O’Connor may have succumbed to political pressure from the inner circle, influencing his medical decisions and aiding in the cover-up — legitimizes the public’s concerns that Dr. O’Connor was not forthright in carrying out his ultimate duties to the country,’ the report said.

‘The Committee recommends that the District of Columbia Board of Medicine review the actions taken by Dr. O’Connor while serving as the White House physician to President Biden for any potential wrongdoing in the medical care of the former president –– including whether Dr. O’Connor produced false or misleading medical reports to the American people.’

O’Connor’s lawyers previously told Fox News Digital that he invoked the Fifth Amendment over concerns that the scope of the committee’s probe could run afoul of doctor-patient confidentiality standards.

Biden’s allies have repeatedly denounced Comer’s probe as political and having no basis in reality. 

Multiple people who spoke with the committee have argued that concerns about Biden’s mental acuity were made worse by the media and Republican pundits, particularly after his disastrous June 2024 debate against current President Donald Trump.

In an interview with The New York Times in July, Biden affirmed he ‘made every decision’ on his own.

This post appeared first on FOX NEWS

President Barack Obama was angry with former House Speaker Nancy Pelosi for her quick endorsement of former Vice President Kamala Harris after President Joe Biden withdrew from the 2024 election, according to a new book.

An excerpt from ABC News’ Jonathan Karl’s upcoming book, ‘Retribution,’ asserts that Pelosi and Obama had come to an understanding that Harris ‘should not simply be handed the nomination unchallenged.’ Nevertheless, Pelosi handed her an endorsement within 24 hours of Biden’s withdrawal.

‘The Obamas were not happy,’ a source close to Pelosi told Karl, according to an excerpt obtained by the Daily Mail.

‘This person summed up Obama’s message to Pelosi as, essentially, ‘What the f–k did you just do?’’ Karl wrote.

The book asserts that Obama had deep concerns about Harris’ ability to beat President Donald Trump and wanted Democrats to hold an open convention.

‘Obama and Pelosi — arguably the two most influential figures in the Democratic Party — had privately agreed to abstain from making any endorsements,’ Karl wrote.

‘The former president wanted to know what had happened. Why had Pelosi issued a statement endorsing Harris so soon? Hadn’t he and Pelosi agreed days earlier that party leaders anointing the vice president as Biden’s replacement would be a mistake?’ Karl added.

Obama gave Pelosi an angry phone call, during which Pelosi argued ‘that train has left the station,’ when Biden endorsed Harris during his withdrawal message.

The source close to Pelosi claimed Obama sounded ‘genuinely irritated’ on the call.

Obama himself ultimately waited five days after Biden’s withdrawal before offering his endorsement to Harris in a joint phone call with his wife, Michelle.

‘We called to say Michelle and I couldn’t be prouder to endorse you and do everything we can to get you through this election and into the Oval Office,’ Obama said.

Michelle chimed in, ‘I am proud of you. This is going to be historic.’

This post appeared first on FOX NEWS

U.S. airline travelers are beginning to feel the effects of the ongoing government shutdown. And with no clear end in sight, it’s increasingly likely that Americans could be grappling with flight delays and cancellations just ahead of the Thanksgiving holiday.

Tuesday marks Day 28 of the shutdown. It’s also the first day that air traffic controllers and other federal workers will see a paycheck showing $0 — putting added strain on a sector that is already dealing with a declining workforce and difficult employment conditions.

‘This Democrat-led shutdown is putting an unnecessary strain on our nation’s aviation system, putting more flights at risk for delays or cancellation,’ Rep. Troy Nehls, R-Texas, chair of the House Transportation Committee’s aviation subcommittee, told Fox News Digital.

After speaking with air traffic controllers directly, Nehls said, ‘They’ve shared their growing concerns about fatigue, distraction and financial hardship as they continue performing essential work without pay.’

‘The busy holiday season is quickly approaching, and the traveling public deserves a safe, efficient, and reliable travel experience. If Senate Democrats continue to refuse to do the right thing and pass the clean continuing resolution, the situation will only get worse,’ Nehls said.

Still, the looming payday hasn’t loosened Senate Democrats from their dug-in position. 

Sen. Andy Kim, D-N.J., argued that the blame game against Democrats over air traffic controllers, and other looming issues like federal food benefits soon running out of money, were ‘all things that the Republicans have been cutting back on.’ 

He noted to Fox News Digital that the administration fired hundreds of Federal Aviation Administration (FAA) employees earlier this year based on recommendations from the Department of Government Efficiency (DOGE). 

‘These are things that they’ve constantly been attacking and putting the strain and pressure on air traffic controllers, and now they’re pretending like they care about this, and I just find that to be disingenuous,’ Kim said. ‘And it’s just using our federal workers as pawns when we know that this administration has done everything that they could to decimate and dismantle our civil service and our public service.’

The Senate may vote on a bill this week from Sen. Ted Cruz, R-Texas, that would pay air traffic controllers, but so far Senate Majority Leader John Thune, R-S.D., has not teed it up. Thune said they’d ‘see what the temperature is of our senators’ on that and other funding issues, but he reiterated that the easiest way to pay all federal workers would be to reopen the government. 

Sen. Richard Blumenthal, D-Conn., echoed a sentiment many Senate Democrats have shared about Cruz’s bill and others like it that would incrementally fund parts of the government; it can’t give President Donald Trump ‘carte blanche to do what he wants.’ 

When asked by Fox News Digital about criticism from Republicans over congressional Democrats’ role in air traffic controllers missing a pay day, he said, ‘Air traffic controllers have been really admirable in coming to work and doing their job.’

Cruz said that he hoped his bill would get a shot, and when asked what his message to Republicans would be to get the bill on the floor, he said, ‘That the Democrats not paying air traffic controllers is reckless.’  

Some 13,000 air traffic controllers are employed across the U.S. Many already work six days per week, faced with a long-simmering shortage of employees.

Because air traffic controllers are deemed essential workers, they are made to work during shutdowns without pay. Instead, they are expected to get back pay when the shutdown is over.

Transportation Secretary Sean Duffy warned late last week that it would mean that many air traffic controllers would be forced to take on another job to make ends meet.

‘If you have a controller that’s working six days a week but has to think about, ‘How am I going to pay the mortgage, how am I to make the car payment, how am I going to put food on my kid’s table?’ They have to make choices, and the choice they’re making is to take a second job,’ Duffy said. ‘I don’t want them delivering for DoorDash. I don’t want them driving Uber. I want them coming to their facilities and controlling the airspace.’

And the effects are being felt already, even far outside of Washington, D.C., where Congress is still gridlocked over federal spending.

Los Angeles International Airport, one of the world’s busiest airports, was forced to issue a temporary ground stop on Sunday morning due to a shortage of air traffic controllers.

It was just one of 22 locations that faced disruptions over air traffic controller shortages on Sunday, Duffy told ‘Sunday Morning Futures.’

There were more than 3,300 delayed flights across the U.S. as of late Monday afternoon, according to airline tracker FlightAware. There were more than 8,700 delays on Sunday.

And several airports, including in Dallas, Austin and Newark, were all under ‘ground delay’ or ‘ground stop’ advisories early Monday evening, according to advisory bulletins from the FAA. Each advisory was due to staffing issues. 

Sen. Roger Marshall, R-Kan., noted that there were ‘three or four’ fast-approaching pressure points, including the payday for air traffic controllers, that could shake loose deeply entrenched Senate Democrats. 

He noted that it wouldn’t be something inside the walls of Congress that could force negotiations, but ‘something extraneous that forces us to come together.’

‘I think the air traffic control has the most potential to light this place up,’ he told Fox News Digital. ‘If the senators can’t go home Thursday night because of air traffic control issues, then I think it really could be a pressure point.’

This post appeared first on FOX NEWS

Investor Insight

Cartier Resources presents a compelling gold investment opportunity, driven by a growing Abitibi resource, solid institutional support, and upcoming development milestones.

Overview

Cartier Resources (TSXV:ECR,FSE:6CA) is a Quebec-based gold exploration company advancing a compelling growth story anchored in one of Canada’s most prolific gold regions — the Abitibi Greenstone Belt. With a focused strategy, institutional support and a commitment to innovation, Cartier is building a significant gold resource base while positioning its flagship Cadillac project as an emerging mining camp east of Val-d’Or. As the company transitions from explorer to potential developer, the coming months present multiple catalysts for a significant valuation uplift.

Cartier projects in the Abitibi Greenstone Belt in Quebec

The Cadillac project has evolved from a single mine project into an emerging gold camp with multiple deposits, advanced resource modeling, and a clear development path. Located in a mining-friendly jurisdiction with existing infrastructure, the Cadillac project is ideally positioned to attract development partners, strategic investments, or acquisition interest from senior producers.

In 2023, using a gold price of US$1,750, Cartier completed a preliminary economic assessment (PEA) which confirmed the project’s robust economics, with a production forecast of 116,900 oz/year over 9.7 years and a low AISC of US$755/oz.

With permitting pathways de-risked by historical mining activity and extensive drilling already completed, Cartier has launched a fully funded 100,000-metre diamond drilling program. By combining AI and geostatistical reinterpretation techniques with traditional exploration methods, the company is positioning itself at the forefront of modern mineral discovery.

The Cadillac project has all the hallmarks of a high-potential development-stage gold asset: grade, scale, jurisdiction, infrastructure, and strategic backing. Cartier is also actively pursuing parallel value-creation opportunities, including the reprocessing of legacy tailings at the Chimo site and monetization of non-core assets like Wilson, Fenton and Benoist.

Company Highlights

  • District-Scale Gold Project: Cadillac: Cartier’s core asset consolidates the former Chimo Mine and East Cadillac properties into a district-scale land package on the prolific Larder Lake-Cadillac Fault — host to more than 100 million ounces of historic gold production.
  • Aggressive Exploration Program: In 2025, Cartier launched a 100,000-meter drill program — one of the largest in the region — to expand its substantial gold resources and unlock Cadillac’s camp-scale potential.
  • Innovation in Discovery: The company is leveraging AI-assisted mineral discovery tools, in partnership with VRIFY, to sharpen drill targeting and accelerate new discoveries.
  • Strategic Partnership with Agnico Eagle: Agnico Eagle, Cartier’s largest shareholder with a 28 percent equity stake, provides financial strength and validates the company’s assets and strategy.
  • ESG-Friendly Tailings Reprocessing: Cartier has introduced a low-capex initiative to evaluate reprocessing 600,000 tons of historic tailings, representing a potential near-term revenue stream with ESG benefits.
  • Attractive Valuation With a clean share structure and a market cap of C$52.9 million, Cartier offers significant re-rating potential as exploration and development catalysts unfold.

Key Projects

Cadillac Project

The company’s flagship Cadillac project is a consolidated land package totaling 11,525 hectares, located along a 15-kilometre strike of the Larder Lake–Cadillac Fault (LLCF) — one of the most productive gold-bearing structures in Canada. This fault zone has historically produced over 100 million ounces of gold across multiple camps. Cartier’s land package includes the past-producing Chimo Mine (379,012 oz gold from 1964 to 1997), West Nordeau, and several new discovery zones over a 10-km strike length straddling the LLCF.

Cartier has completed four mineral resource estimates (MREs) between 2019 and 2022. The most recent, published in May 2023, outlined 7.1 million tons (Mt) @ 3.1 grams per ton (g/t) gold (720,000 oz) indicated and 18.5 Mt @ 2.8 g/t gold (1.63 Moz) inferred. The PEA evaluated an underground mining operation fed from three primary zones (Chimo, East Chimo, West Nordeau), with a 2.9-year payback on a C$341 million capex. The PEA assumes an average head grade of 3.0 g/t gold and annual production of 116,900 oz gold. Infrastructure advantages include an existing shaft, power line and permitted tailings facility.

Cartier Resources has commenced its fully funded 100,000-metre drill program at the Cadillac Project in Quebec, the largest ever on the property. The 18-month campaign is designed to both expand known gold zones and test new high-priority targets along the Cadillac Fault Zone. With $11 million in cash and no debt, Cartier is well positioned to advance Cadillac’s district-scale gold potential.

Chimo Tailings Project

As part of Cartier’s sustainability-focused development strategy, the company is evaluating the potential for reprocessing approximately 600,000 tons of historical tailings deposited during the Chimo Mine operations. This project could unlock near-term, low-cost production with a minimal environmental footprint. Cartier will launch metallurgical characterization to assess gold recovery potential and economic viability. The project benefits from proximity to several underutilized gold mills in the Val-d’Or region, potentially enabling toll milling agreements.

Other Projects: Wilson, Fenton and Benoist

Cartier also holds 100 percent ownership of three additional gold projects — Wilson, Fenton and Benoist — all located within the Abitibi Belt and each hosting historical gold mineralization or compliant resources. The Wilson Project (1,750 ha, three zones), Fenton (671 ha, 12 zones) and Benoist (3,086 ha, two zones) are currently available for joint ventures or sale. These assets offer significant exploration upside and optionality, allowing Cartier to remain focused on Cadillac while preserving long-term value.

Management Team

Philippe Cloutier – Founder, President, CEO and Director

Philippe Cloutier is the founder and driving force behind Cartier Resources. A professional geologist with over 35 years of experience in the exploration and development of precious and base metal deposits, Cloutier has a deep technical understanding of the Abitibi Greenstone Belt, having spent most of his career advancing projects in this prolific region.

Nancy Lacoursière – Chief Financial Officer

Nancy Lacoursière brings over 20 years of experience in corporate finance, accounting and strategic financial management. She has held CFO and senior finance positions across the natural resources and manufacturing sectors, with a strong focus on Quebec-based operations.

Ronan Déroff – VP of Exploration

Ronan Déroff is a senior exploration geologist and Cartier’s designated qualified person under NI 43-101. With over 15 years of experience in mineral exploration, resource modeling, GIS and project management, Déroff leads the technical execution of Cartier’s exploration strategy. He has overseen the development of multiple MREs and PEAs for the Cadillac project, and played a central role in integrating modern data analysis and AI-assisted targeting into the company’s workflow. He holds a Masters in operations and management of mineral resources (EGERM), from the Université d’Orléans (France).

This post appeared first on investingnews.com

The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries.

Public biotech indexes rallied above critical levels last seen in 2021, with the NASDAQ Biotech Index (INDEXNASDAQ:NBI) closing 21 points ahead for the quarter and up 11 percent year-to-date.

Emerging artificial intelligence (AI) applications are becoming increasingly critical in drug discovery and R&D, highlighted by products like AlphaFold and new draft guidance from the US Food and Drug Administration (FDA) that encourages AI use in regulatory submissions. However, cautious funding approaches remain, especially for early stage companies.

This confluence may signal a sector resurgence, despite continued funding caution for early stage firms.

Biopharma M&A activity picks up

In a Q3 report on M&A activity, Oppenheimer notes that biopharma market sentiment showed an upward trajectory during the quarter, with expectations that deal flow will continue to increase through the end of 2025.

William Blair, a global investment banking and asset management firm specializing in biopharma investments, also notes an uptick in momentum in a recap of Q2 activity in the biopharma space, citing positive clinical data, a wave of public M&A activity and more clarity on tariffs and drug pricing as catalysts.

Total M&A transaction value reached US$38 billion for the quarter, according to data analyzed by Oppenheimer, including US$20 billion in September alone. Clinical-stage acquisitions saw their strongest quarter since late 2023, driven by early stage assets in the oncology, immunology and cardiovascular-metabolic areas.

The central nervous system space saw a pause in deals for the first time since the beginning of 2024, reflecting shifting investment priorities. Small molecules and antibodies maintained their leading positions as prevalent treatment modalities in deals, while emergents like bispecific antibodies, multi-specific antibody-drug conjugates and CAR-T therapies gained traction. However, the overall M&A market for antibody-drug conjugates remained cautious, with the exception of Seribant Therapeutics’ acquisition of Y-mAbs Therapeutics for US$412 million.

Public company takeouts continued to outnumber private company acquisitions for the second consecutive quarter; however, private companies still attracted strong interest from investors after a sluggish first half of 2025.

Oppenheimer’s Private Placement Activity report notes that a significant increase was observed in September, with companies with a clinical pipeline and a platform commanding the highest valuations.

Strategic partnerships between established pharmaceutical leaders and innovative biotech firms continued to underscore the ongoing efforts by pharma leaders to build and diversify their pipelines.

Roche Holding (OTCQX:RHHBY,SWX:ROG) and Zealand Pharma (OTC Pink:ZLDPY,CPH:ZEAL) entered into an agreement to co-develop and co-commercialize weight-loss drug candidate petrelintide in a deal valued at up to US$5.3 billion, reflecting ongoing interest in weight-management therapies, despite market challenges and competitive pressure.

Meanwhile, Bristol-Myers Squibb (NYSE:BMY) and BioNTech (NASDAQ:BNTX) agreed to co-develop and co-commercialize a novel cancer immunotherapy targeting multiple tumor types in a deal worth up to US$11 billion, and Pfizer (NYSE:PFE) partnered with 3SBio (OTC Pink:TRSBF,HKEX:1530) to advance a new cancer drug candidate.

Both agreements highlight ongoing efforts to expand oncology treatment options.

Cell and gene therapies continued to draw investor attention, and the central nervous system space saw an increase in average deal size. William Blair notes that cell and gene therapies remain a priority area for venture capital investors, as well as public market investors, despite regulatory complexities.

Initial public offering (IPO) activity rebounded meaningfully in Q3 after a quieter first half of 2025, with LB Pharmaceuticals’ (NASDAQ:LBRX) September offering serving as a marker of renewed capital markets appetite.

Secondary public offerings and clinical-stage private financings also increased, fueled by promising clinical data and expanding investor participation, including from international markets such as China.

In parallel, funding for AI-driven drug discovery platforms continued to capture investor interest, with rounds for companies like Isomorphic Labs, Pathos and Lila Sciences.

Regulatory and policy developments

US President Donald Trump’s second term has brought a shift to more business-friendly stances, impacting healthcare M&A and trade. The Federal Trade Commission has signaled intentions to ease antitrust scrutiny, potentially speeding up big pharma and biotech dealmaking and encouraging higher transaction volumes that consolidate the sector.

A central policy focus is the onshoring of biopharmaceutical manufacturing, with the administration actively pursuing tariff negotiations to reduce import costs and bolster supply chain resilience. The landmark deal between the government and Pfizer to lower drug prices in Medicaid in exchange for tariff relief exemplifies this dual approach.

These tariff adjustments are designed to ease the burden on drug importation costs, incentivizing companies to invest more domestically while managing global supply chain risks. Lara Castleton, US head of portfolio construction and strategy at Janus Henderson Investors, has identified this agreement as “the catalyst for healthcare.” She further suggests that the sector is likely overdue for a comeback, having lagged behind the tech market earlier in the year.

Trump has emphasized the expectation that other pharma companies will follow suit, intensifying onshoring efforts. As of September 30, large pharma had committed roughly US$368 billion to US-based manufacturing facilities.

Additionally, the FDA approved 45 new drug applications in Q3, marking a notable increase from previous quarters. This surge was driven by accelerated approvals, largely in the gene and cell therapy sectors, as well as innovative biologics targeting rare diseases and oncology.

Biotech and pharma market forecast for 2025

The biotech and pharma sectors entered Q4 on firm footing. Supportive market dynamics are expected to persist as the year continues, with 2025 on track to reach US$93 billion in total transaction value.

Several catalysts are poised to shape the healthcare landscape moving forward.

An anticipated IPO from MapLight Therapeutics, focusing on neurology therapies, will reveal investor appetite for specialty pharma assets in a market that had a bullish close to Q3, but faces questions about sustaining momentum.

On the regulatory front, FDA decisions are expected for a handful of treatments in gene and cell therapy, as well as oncology. Approvals are expected to accelerate, bolstered by programs aimed at speeding up evaluations of novel treatments like CRISPR-based medicines, stem cell research and nutraceuticals.

Leadership changes may also foster innovation in unconventional medical fields such as stem cell research and nutraceuticals. Amid an evolving regulatory and political landscape, Reed Jobs has advocated for sustained public funding to fuel biomedical progress, delivering a key congressional address on National Institutes of Health protection in September. Beyond advocacy, he is also building a nearly US$1 billion biotech fund focused on next-generation cancer therapies, highlighting the vital intersection of public research funding and private sector innovation.

Policy clarity around drug pricing reforms and Medicaid tariff relief will critically influence commercial access and pricing dynamics. The GLP-1 sector remains under the spotlight following the announcement of Trump’s plans to reduce the monthly cost of GLP-1 drugs like Ozempic and Wegovy to US$150.

AI’s expanding role in drug discovery, clinical trial design and digital therapeutics will continue to inspire industry innovation, likely attracting significant funding and fostering new collaborations.

However, volatility related to regulatory appointments, trade uncertainties and notably the ongoing US federal government shutdown presents near-term challenges. Investors and industry participants will closely monitor clinical data and regulatory shifts to navigate the evolving landscape successfully.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Here’s a quick recap of the crypto landscape for Friday (October 24) as of 5:00 p.m. UTC.

Get the latest insights on Bitcoin, Ether and altcoins, along with a round-up of key cryptocurrency market news.

Bitcoin and Ether price update

Bitcoin (BTC) was priced at US$110,645, a 0.3 percent increase in 24 hours. Its lowest valuation of the day was US$109,873, and its highest was US$111,266.

Bitcoin price performance, October 24, 2025.

Chart via TradingView.

Bitcoin’s medium-sized investors are continuing to buy even after the US$19 billion liquidation event earlier this month, preserving the market’s long-term bullish structure, according to CryptoQuant.

Entities holding between 100 and 1,000 BTC have added roughly 907,000 BTC over the past year, which analysts say represents a strong accumulation trend that historically aligns with upward price momentum.

Recent price action reflects this institutional backing, with Bitcoin reclaiming levels above US$110,000 amid softer inflation data and improved market sentiment. However, CryptoQuant warned that short-term demand is softening as the cohort’s 30-day balance has fallen below its moving average, suggesting potential near-term caution until a catalyst, such as renewed exchange-traded fund (ETF) inflows, emerges.

Ether (ETH) was priced at US$3,928.56, a 1.8 percent increase in 24 hours. Its lowest valuation of the day was US$3,872.67, and its highest was US$3,968.61.

Altcoin price update

  • Solana (SOL) was priced at US$193.09, at its highest valuation of the day, up by 0.9 percent over the last 24 hours. Its lowest valuation of the day was US$189.23.
  • XRP was trading for US$2.51, an increase of 4.2 percent over the last 24 hours and its highest valuation of the day. Its lowest was US$2.46.

Crypto derivatives and market indicators

The cryptocurrency market has experienced some fluctuations with a mixed but generally cautious outlook. The crypto derivatives market has shown some signs of recovery and increased activity after the earlier October volatility.

Liquidations for contracts tracking Bitcoin have totaled approximately US$5.89 million in the last four hours, the majority of which have been short positions, indicating a possible short squeeze or short-covering rally.

This aligns with Bitcoin’s price rebound and trader repositioning after recent dips.

Ether liquidations showed a different pattern; its US$7.01 million liquidations were fairly evenly split between long and short positions, suggesting balanced market dynamics and some ongoing indecision or consolidation.

Futures open interest for Bitcoin was up by 0.4 percent to US$71.27 billion over four hours, indicating growing trader interest and increasing liquidity, with a slight decrease in the final hour of trading. Ether futures open interest moved by +0.86 percent to US$45.94 billion, also showing a modest pullback as markets closed.

The funding rate remains positive, with both Bitcoin and Ether showing it at 0.005, a sign of modest bullish sentiment but not extreme leverage. Bitcoin’s relative strength index stood at 55.4, in a neutral to slightly bullish momentum phase, further supporting a stable recovery rather than a parabolic move.

Fear and Greed Index snapshot

CMC’s Crypto Fear & Greed Index has slightly trended upwards into 32, but remains in fear territory, an improvement from this week’s lowest score (25).

CMC Crypto Fear and Greed Index, Bitcoin price and Bitcoin volume.

Chart via CoinMarketCap

Today’s crypto news to know

Trump pardons Binance founder

US President Donald Trump has granted a full pardon to Binance founder Changpeng Zhao, wiping away his 2024 conviction for violating US anti-money laundering laws. Zhao, better known as “CZ,” served four months in prison and had been barred from running financial ventures under the plea deal.

The move follows months of lobbying by Binance, which paid a record US$4.3 billion fine as part of its own settlement with federal prosecutors. White House Press Secretary Karoline Leavitt called the case “a politically motivated overreach by the Biden administration,” insisting the pardon was meant to correct an injustice.

Critics argue the decision reflects Trump’s growing financial ties to the crypto industry, citing his personal investments and recent push for a “national cryptocurrency reserve.” Zhao thanked Trump on social media, saying he is “deeply grateful” for the decision and eager to “continue supporting innovation responsibly.”

Bitfarms surges on Jane Street investment

Crypto miner Bitfarms (TSX:BITF) saw its shares surge on Friday after trading firm Jane Street said it has acquired a 5.4 percent ownership stake in the company, as well as a 5 percent stake in Cipher Mining (NASDAQ:CIFR).

This move from a major institutional market maker, known for its strategic investments in the digital asset space, highlights the growing institutional involvement in cryptocurrency mining businesses and their expanding role within the tech sector’s market rally.

Polymarket confirms POLY token launch

Prediction platform Polymarket has confirmed plans to launch its long-awaited POLY token following a US$2 billion investment from Intercontinental Exchange (ICE), the parent company of the New York Stock Exchange.

Speaking on the Degenz Live podcast, Chief Marketing Officer Matthew Modabber said both the token and airdrop are “officially in motion,” confirming rumors that have swirled for months.

Modabber emphasized that the launch will prioritize real utility and “long-term viability,” aligning with Polymarket’s push to relaunch its US app after receiving fresh regulatory clearance.

Sygnum Bank, Debifi partner for multiSYG Bitcoin lending product

Sygnum Bank has partnered with Debifi, a Bitcoin-backed lending platform, to introduce MultiSYG, a new multisignature Bitcoin lending product slated for launch in the first half of 2026.

MultiSYG allows clients to borrow fiat currencies against their Bitcoin holdings. These Bitcoin assets are held in a 3-of-5 multisig escrow wallet, with keys distributed to the borrower, Sygnum and independent signers. This structure ensures borrowers maintain partial control and on-chain cryptographic proof of their collateral for the loan term.

The product is designed to enhance transparency and security in lending by preventing rehypothecation and eliminating the need for blind trust in custodians, which are common issues in traditional lending practices. MultiSYG is specifically tailored for institutional and high-net-worth clients seeking bank-grade terms and flexible loan services.

JPMorgan to let institutions borrow against Bitcoin, Ether holdings

JPMorgan Chase (NYSE:JPM) is preparing to let its institutional clients borrow cash using Bitcoin and Ether as collateral. Set to launch by the end of 2025, the initiative will allow the firm’s clients to pledge cryptocurrencies directly rather than through ETFs, using a third-party custodian to safeguard tokens.

The pilot follows successful internal testing involving BlackRock’s iShares Bitcoin Trust ETF (NASDAQ:IBIT) earlier this year. JPMorgan already accepts crypto-linked ETFs as loan collateral.

Crypto.com applies for national trust bank charter

Crypto.com has applied to the US Office of the Comptroller of the Currency for a National Trust Bank Charter.

This federal charter would enable Crypto.com to provide regulated crypto financial services across the US, including custody and staking. The company plans to focus on institutional clients, offering solutions such as digital asset treasuries, ETFs and corporate custody. This move signifies Crypto.com’s progression towards compliance with traditional financial regulations and the expansion of its regulated presence in the US.

Securities Disclosure: I, Giann Liguid, hold no direct investment interest in any company mentioned in this article.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Tight export controls out of the Democratic Republic of Congo (DRC) added tailwinds to cobalt prices in Q3, prompting market watchers to anticipate a shift from oversupply to balance in the coming months.

After starting the year at lows unseen since 2016 (US$21,502 per metric ton), cobalt began to rebound in Q2.

Prices for the metal then flatlined in the US$33,300 to US$37,000 range from the end of March through September, but a sharp rally in late October sent values to US$47,110, a level last reached in January 2023.

Cobalt price, October 25, 2024, to October 23, 2025.

Chart via Trading Economics.

Much of the cobalt story this year has been dominated by the February export suspension out of the DRC, which supplies roughly three-quarters of the world’s cobalt. The initial curtailment was expected to last four months in an effort to rein in oversupply and stem a price plunge below US$10 per pound, the lowest point in over 20 years.

The supply glut has been attributed to a surge in output driven largely by China’s CMOC Group (OTC Pink:CMCLF, SHA:603993), which has rapidly expanded production at two major DRC mines.

Cobalt supply expected to swing from surplus to balance

Cobalt supply has surged over the past five years, with global mine production more than doubling from 140,000 metric tons in 2020 to 290,000 metric tons in 2024. The bulk of this growth has come out of DRC, with annual output rising from 175,000 metric tons in 2023 to 220,000 metric tons in 2024. This rapid growth has far outpaced demand from the electric vehicle (EV) sector and other end-use industries, resulting in significant market oversupply.

In June, the DRC extended its export halt through September, a move that supported higher price levels.

“Trade statistics for cobalt hydroxide imports into China in June showed the first drop in material following the export ban enforcement in late February,” wrote Fastmarkets’ Rob Searle in a June market update.

“With a typical lead time of around three months, we expected June to be the first month of lower volumes. Cobalt hydroxide imports fell 62 percent in June and are expected to remain at low levels through to the end of December or early 2026. Should the export ban end as planned on September 22, the end of the year is the earliest we can expect to see new feed into the Chinese market from the DRC,’ the battery metals expert continued.

As the deadline for the export halt extension drew near, prices began to climb amid rumors that officials in Kinshashe would implement quotas to continue curbing the market saturation.

After eight months of restricted trade, the Authority for the Regulation and Control of Strategic Mineral Substances’ Markets (ARECOMS), announced it was enacting a quota system aimed at stabilizing global supply and prices.

The output cap will permit the export of 18,125 metric tons of DRC cobalt for the remainder of 2025.

“In 2026, the annual quota is set at 96,600t, of which 87,000t will be distributed to producers on a pro rata basis, with 9,600t retained under ARECOMS’ discretionary control,” a September Benchmark Mineral Intelligence report notes. “The framework will run through 2027, with adjustments possible if officials deem the market ‘imbalanced.”

The restrictions lifted cobalt prices to a 32 month high of US$48,570 on October 23.

Strong cobalt demand projected for next two years

Although the cobalt market remains oversupplied, demand has steadily increased alongside ballooning output, reaching record levels of more than 200,000 metric tons in 2024.

“The primary growth driver of this (growth) is the electric vehicle market, combined with portables, which is the second biggest battery market,” explained Benchmark’s William Talbot during a July Cobalt Institute webinar.

The alloy and military applications segment also experienced growth.

Talbot went on to note that despite reports that EV demand is waning in some regions, broad demand remains robust, and EVs that utilize cobalt battery chemistries “are still growing at pace.”

“If we look at the EV picture year-to-date in 2025, we’ve had more than 30 percent growth compared to the same period last year in unit terms,” he explained.

Cobalt price growth to continue into 2026

The cobalt market is entering a phase of continued volatility and structural change, shaped by shifting supply sources, evolving policy frameworks and growing geopolitical tension, as per Benchmark’s Talbot and the Cobalt Institute.

Looking ahead, Benchmark expects Indonesia to overtake the DRC as the key source of new supply by the late 2020s, as projects such as Kalimantan Ferro Nickel ramp up and few new developments emerge in the DRC.

On the demand side, Talbot said the outlook remains “fairly robust,” with EV growth driving consumption, despite some policy headwinds in the US. He pointed to China’s planned ban on lithium iron phosphate (LFP) battery technology, which he said “is supportive of cobalt-containing chemistries” such as nickel cobalt manganese (NCM).

Rising geopolitical tensions are also reshaping the cobalt supply chain.

“Major players are increasingly cognizant of where their materials come from,” Talbot said, citing new US and European investment in strategic and ESG-compliant cobalt projects.

Talbot added that the cobalt value chain has made “leaps and bounds” in sustainability, with roughly 80 percent of refined cobalt now assessed under the Responsible Minerals Initiative — a key factor for automakers and original equipment manufacturers under tightening compliance requirements.

While Benchmark remains cautious with projections, analysts at Project Blue say cobalt prices could rebound sharply in 2026 and 2027 as the DRC enforces its new export cap of 96,600 metric tons per year.

“Such constraints could lift cobalt prices toward historical real levels of over US$20 per pound,” reads a Project Blue report, noting that the quota “came in lower than many expected,” but aligns with its call for a rebalanced market.

According to Project Blue, at least 100,000 metric tons of exports would be needed next year to maintain equilibrium. Accounting for shipping delays and processing losses, only 85,000 to 90,000 metric tons are expected to reach end users — creating a structural deficit that should continue to support prices. The quota framework could also spur domestic refining as export restrictions make long-term storage of cobalt hydroxide costly.

Industry observers warn that producers — especially copper-cobalt miners such as CMOC — may need to adopt financial hedging and adjust production plans to navigate the added bureaucracy and potential export delays.

Similarly, Fastmarkets expects the DRC’s new rules to support cobalt prices, which have already soared more than 240 percent since February, Alexander Cook wrote in an LME Week recap. Fastmarkets assessed cobalt hydroxide prices at US$19.50 to US$20.20 on October 14, up from just US$5.65 in February.

The restrictions have sharply curtailed available volumes — much of which are already locked into long-term contracts — leaving the spot market increasingly constrained, wrote Cook.

Market participants expect further gains, though analysts caution that such elevated prices could push some battery makers to accelerate the shift toward cobalt-free chemistries such as LFP.

While the quota system has bolstered prices in the short term, the long-term outlook remains uncertain.

Analysts note that cobalt’s fate is increasingly tied to copper market dynamics and the pace of EV demand recovery, with downstream buyers and automakers reassessing cobalt’s role in next-generation batteries.

Securities Disclosure: I, Georgia Williams, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Questcorp Mining Inc. (CSE: QQQ,OTC:QQCMF) (OTCQB: QQCMF) (FSE: D910) (the ‘Company’ or ‘Questcorp’) announces that it has closed the first tranche of its non-brokered private placement (the ‘Offering’). In connection with closing, the Company has issued 14,000,334 units (each, a ‘Unit’) at a price of $0.15 per Unit for gross proceeds of $2,100,050. Each Unit consists of one common share of the Company (each, a ‘Share’) and one-half-of-one share purchase warrant (each whole warrant, an ‘Warrant’). Each Warrant entitles the holder to acquire an additional common share of the Company at a price of $0.20 until October 24, 2027, subject to accelerated expiry in the event the closing price of the Shares is $0.50 or higher for ten consecutive trading days.

The Company expects to utilize the proceeds of the Offering for advancement of ongoing exploration and drill work at the La Union Gold and Silver Project, upcoming exploration work at the North Island Copper Property, and for general working capital purposes.

A portion of the Units issued under the first tranche the Offering, representing $2,000,000 will be held pursuant to a sharing agreement entered into with an institutional investor, Sorbie Bornholm LP (‘Sorbie‘) and the Company (the ‘Sharing Agreement‘). The Sharing Agreement provides that the Company’s economic interest will be determined in twenty-four monthly settlement tranches as measured against the Benchmark Price (as defined herein). If, at the time of settlement, the Settlement Price (determined monthly based on a volume-weighted average price for twenty trading days prior to the settlement date) (the ‘Settlement Price‘) exceeds the benchmark price of $0.1949 (the ‘Benchmark Price‘), the Company shall receive more than one-hundred percent of the monthly settlement due, on a pro-rata basis. There is no upper limit placed on the additional proceeds receivable by the Company as part of the monthly settlements. If, at the time of settlement, the Settlement Price is below the Benchmark Price of $0.1949, the Company will receive less than one-hundred percent of the monthly settlement due on a pro-rata basis. In no event will a decline in the Settlement Price of the Units result in an increase in the number of Units being issued to Sorbie.

The Units issued to subscribers in the first tranche of the Offering were issued pursuant to the listed issuer financing exemption (the ‘Listed Issuer Financing Exemption‘) under Part 5A of National Instrument 45-106 – Prospectus Exemptions (‘NI 45-106‘). As a result, they are not subject to statutory hold periods. In connection with the Listed Issuer Financing Exemption, the Company has prepared and filed an offering document related to the Offering that is available under the Company’s profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at: www.questcorpmining.ca. Prospective investors should read this offering document before making an investment decision. No finders’ fees or commissions were paid in connection with completion of the first tranche of the Offering, but Sorbie received a corporate finance fee in the amount $130,000 payable through the issuance of 866,667 Units at price of $0.15 per Unit.

The Company anticipates completing a further tranche of the Offering for up to a further 9,333,000 Units, to bring combined gross proceeds from the Offering to $3,500,000. The Company anticipates that the remaining Units will be offered to subscribers pursuant to the accredited investor exemption (the ‘Accredited Investor Exemption‘) under Section 2.3 of NI 45-106. All securities issued pursuant to the Accredited Investor Exemption will be subject to restrictions on resale for a period of four-months-and-one-day in accordance with applicable securities laws. In connection with completion of the remaining tranche of the Offering, the Company may pay finders’ fees to eligible third-parties who have introduced subscribers to the Offering. Completion of a final tranche of the Offering remains subject to receipt of regulatory approvals.

About Questcorp Mining Inc.

Questcorp Mining Inc. is engaged in the business of the acquisition and exploration of mineral properties in North America, with the objective of locating and developing economic precious and base metals properties of merit. The Company holds an option to acquire an undivided 100% interest in and to mineral claims totaling 1,168.09 hectares comprising the North Island Copper Property, on Vancouver Island, British Columbia, subject to a royalty obligation. The Company also holds an option to acquire an undivided 100% interest in and to mineral claims totaling 2,520.2 hectares comprising the La Union Project located in Sonora, Mexico, subject to a royalty obligation.

Contact Information

Questcorp Mining Corp.
Saf Dhillon, President & CEO
Email: saf@questcorpmining.ca
Telephone: (604) 484-3031

This news release includes certain ‘forward-looking statements’ under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements with respect to the intended use of proceeds from the Offering. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: the ability of Riverside to secure geophysical contractors to undertake orientation surveys and follow up detailed survey to confirm and enhance the drill targets as contemplated or at all, general business, economic, competitive, political and social uncertainties, uncertain capital markets; and delay or failure to receive board or regulatory approvals. There can be no assurance that the geophysical surveys will be completed as contemplated or at all and that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/271978

News Provided by Newsfile via QuoteMedia

This post appeared first on investingnews.com

History is being rewritten on the White House grounds, where a new formal ballroom is rising in place of the East Wing. The project has become a political lightning rod, as images of its construction reignite debate over President Donald Trump’s imprint on the nation’s most iconic address.

While the White House has hosted countless ceremonial events, it has never had a dedicated ballroom. The new structure will fill that void, replacing the historic East Wing with a space designed instead to host large-scale gatherings.

The ballroom is estimated to cost $250 million and will be financed jointly by Trump and private donors.

While the White House has pledged to release details on the individuals and corporations funding the ballroom’s construction, a comprehensive breakdown of contributions has not yet been made public.

During a July 31 briefing, White House press secretary Karoline Leavitt detailed the administration’s plans to construct a 90,000-square-foot ballroom on the White House grounds.

Leavitt said the new ballroom will accommodate approximately 650 seated guests and will stay true to the classical design of the White House.

‘The White House is currently unable to host major functions honoring world leaders in other countries without having to install a large and unsightly tent approximately 100 yards away from the main building’s entrance,’ Leavitt said on July 31.

She added that the new ballroom will be ‘a much-needed and exquisite addition.’

This post appeared first on FOX NEWS